PRW Wealth Management’s Exact Sciences EXAS Stock Holding History

PRW Wealth Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3	Closed	–	–	267
2019 Q1	$0	Hold	3	–	–	﹤0.01%	713
2018 Q4	$0	Buy	+3	New	+$206	﹤0.01%	700

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PRW Wealth Management's EXAS Position: Q2 2019 in Review

PRW Wealth Management sold out of Exact Sciences (EXAS) in Q2 2019, closing a stake of 3 shares.

PRW Wealth Management first reported a position in EXAS in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 472 funds tracked by Wall St. Rank hold EXAS as of Q2 2019.

PRW Wealth Management reported no remaining Exact Sciences position as of Q2 2019 after selling out during the quarter.
PRW Wealth Management sold 3 Exact Sciences shares in Q2 2019.
PRW Wealth Management first reported a position in Exact Sciences in Q4 2018 and held it in 2 quarters.
PRW Wealth Management's Exact Sciences position peaked at $0 in Q1 2019.
472 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2019.

Based on PRW Wealth Management's 13F filing for Q2 2019, filed 12 Aug 2019.